CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PANA aims to develop early diagnostic and therapeutic strategies for Alzheimer’s disease by focusing on tau oligomers. The project combines advanced imaging techniques with smart nanoparticles to improve diagnosis and treatment delivery.
Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and limitation of social activities.
Progressive aging of EU population will increase the magnitude of this problem in the next decades.
Currently, there is not an effective method for the early diagnosis of AD.
Therefore, there is an urgent need to develop new effective early diagnostic and therapeutic strategies to help in delaying the appearance of the most a…
SERVIZO GALEGO DE SAUDE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
Spain, Santiago De Compostela
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA LIN
Portugal, Braga
Type: Research institute
Activity type: Research Organisations
SME: No
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Leuven
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
